WPD Pharmaceuticals Inc.
WBIO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -100.14% | -102.80% | -104.71% | -102.21% | -- |
| Total Depreciation and Amortization | 12.50% | -21.62% | -56.49% | -74.87% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.65% | 95.29% | 96.77% | 96.36% | -- |
| Change in Net Operating Assets | 106.32% | 106.27% | 103.23% | 100.81% | -- |
| Cash from Operations | 80.69% | 89.18% | 88.42% | 94.25% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 152.43% | -- | -- | -- | -- |
| Cash from Investing | 103.38% | -- | -- | -- | -- |
| Total Debt Issued | -100.77% | -110.93% | 6.37% | -63.89% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Financing | -96.16% | -104.06% | -65.27% | -77.27% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -200.68% | -- | -- |
| Net Change in Cash | -156.48% | 60.70% | 98.76% | 103.57% | -- |